EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genotypic and Phenotypic Spectrum and Pathogenesis of WNT1 Variants in a Large Cohort of Patients With OI/Osteoporosis

Jing Hu, Xiaoyun Lin, Peng Gao, Qian Zhang, Bingna Zhou, Ou Wang, Yan Jiang iD, Weibo Xia, Xiaoping Xing, Mei Li iD

The Journal of Clinical Endocrinology & Metabolism · 16.06.2023 · 108 (7) · 1776-1786

DOI: 10.1210/clinem/dgac752 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 03.01.2023. Verfasst von Jing Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Key Laboratory of Endocrinology, National Health and Family Planning Commission, Peking Union Medical College Hospital, …. Hauptthemen laut MEDLINE: Osteogenesis Imperfecta, Osteoporosis, Fractures, Bone. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key R&D Program of China, Chinese Academy of Medical Sciences Initiative for Innovative Medicine, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Mutations in WNT1 can cause rare inherited disorders such as osteogenesis imperfecta (OI) and early-onset osteoporosis (EOOP). Owing to its rarity, the clinical characteristics and pathogenic mechanism of WNT1 mutations remain unclear.

Objective

We aimed to explore the phenotypic and genotypic spectrum and treatment responses of a large cohort of patients with WNT1-related OI/OP and the molecular mechanisms of WNT1 variants.

Methods

The phenotypes and genotypes of patients and their responses to bisphosphonates or denosumab were evaluated. Western blot analysis, quantitative polymerase chain reaction, and immunofluorescence staining were used to evaluate the expression levels of WNT1, total β-catenin, and type I collagen in the tibial bone or skin from one patient.

Results

We included 16 patients with 16 mutations identified in WNT1, including a novel mutation. The types of WNT1 mutations were related to skeletal phenotypes, and biallelic nonsense mutations or frameshift mutations could lead to an earlier occurrence of fragility fractures and more severe skeletal phenotypes. Some rare comorbidities were identified in this cohort, including cerebral abnormalities, hematologic diseases, and pituitary adenoma. Bisphosphonates and denosumab significantly increased the spine and proximal hip BMD of patients with WNT1 mutations and reshaped the compressed vertebrae. We report for the first time a decreased β-catenin level in the bone of patient 10 with c.677C > T and c.502G > A compared to the healthy control, which revealed the potential mechanisms of WNT1-induced skeletal phenotypes.

Conclusion

Biallelic nonsense mutations or frameshift mutations of WNT1 could lead to an earlier occurrence of fragility fractures and a more severe skeletal phenotype in OI and EOOP induced by WNT1 mutations. The reduced osteogenic activity caused by WNT pathway downregulation could be a potential pathogenic mechanism of WNT1-related OI and EOOP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Osteogenesis ImperfectaOsteoporosisFractures, BoneHumansbeta CateninCodon, NonsenseDenosumabGenotypePhenotype

Stichwörter der Autor:innen

WNT1 variantsearly-onset osteoporosisosteogenesis imperfectapathogenic mechanism

Substanzen

beta CateninCodon, NonsenseDenosumab

Autor:innen und Institutionen

  • Department of Endocrinology, Key Laboratory of Endocrinology, National Health and Family Planning Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,…
  • Department of Orthopedics, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing 100730, China.

ORCID-Profile: Yan Jiang, Mei Li

Förderung

  • National Key R&D Program of China
  • Chinese Academy of Medical Sciences Initiative for Innovative Medicine
  • National Natural Science Foundation of China
  • Beijing Natural Science Foundation

Zitieren

APA

Hu, J., Lin, X., Gao, P., Zhang, Q., Zhou, B., Wang, O., Jiang, Y., Xia, W., Xing, X., & Li, M. (2023). Genotypic and Phenotypic Spectrum and Pathogenesis of WNT1 Variants in a Large Cohort of Patients With OI/Osteoporosis. The Journal of Clinical Endocrinology & Metabolism, 108(7), 1776-1786. https://doi.org/10.1210/clinem/dgac752

Vancouver

Hu J, Lin X, Gao P, Zhang Q, Zhou B, Wang O, et al. Genotypic and Phenotypic Spectrum and Pathogenesis of WNT1 Variants in a Large Cohort of Patients With OI/Osteoporosis. The Journal of Clinical Endocrinology & Metabolism. 2023;108(7):1776-1786. doi:10.1210/clinem/dgac752

BibTeX
@article{Hu2023,
  author = {Hu, Jing and Lin, Xiaoyun and Gao, Peng and Zhang, Qian and Zhou, Bingna and Wang, Ou and Jiang, Yan and Xia, Weibo and Xing, Xiaoping and Li, Mei},
  title = {Genotypic and Phenotypic Spectrum and Pathogenesis of WNT1 Variants in a Large Cohort of Patients With OI/Osteoporosis},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2023},
  volume = {108},
  number = {7},
  pages = {1776--1786},
  doi = {10.1210/clinem/dgac752}
}
Kostenlos starten →